9. Corrigenda (Rule 231)

The relevant committees had forwarded the following corrigenda to texts adopted by the Parliament:

- Corrigendum P7_TA(2014)0273(COR01) to Regulation (EU) No 536/2014 of the European Parliament and of the Council of 16 April 2014 on clinical trials on medicinal products for human use, and repealing Directive 2001/20/EC (OJ L 158, 27.5.2014, p. 1) (position of the European Parliament adopted at first reading on 2 April 2014 with a view to the adoption of the above regulation P7_TA(2014)0273) - (COM(2012)0369 – C7-0194/2012 – 2012/0192(COD)) - ENVI Committee;

- Corrigendum P7_TA(2013)0115(COR03) to Regulation (EU) No 575/2013 of the European Parliament and of the Council of 26 June 2013 on prudential requirements for credit institutions and investment firms and amending Regulation (EU) No 648/2012 (OJ L 176, 27.6.2013, p. 1) (position of the European Parliament adopted at first reading on 16 April 2013 with a view to the adoption of the above regulation P7_TA(2013)0115) - (COM(2011)0452 – C7-0417/2011 – 2011/0202(COD)) - ECON Committee.

The corrigenda were available on Europarl.

Pursuant to Rule 231(4), these corrigenda would be deemed approved unless, within 24 hours, a request was made by a political group or at least 40 Members that they be put to the vote.